World Generic Markets Issue - Merck KGaA Trial Highlights Growing Potential Biosimilar Adalimumab Market - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "World Generic Markets Issue 279 (V15 I12)" report to their offering.

Whilst not the first to report progress on the development of a biosimilar adalimumab product, Merck KGaA's Phase III study underscores the growing potential market for biosimilar competition for AbbVie's Humira. Biosimilar versions have already been launched in the less regulated Indian market, but other companies are making advances in regulated markets, including the US. US sales are crucial for Humira, as there is no biosimilar competition there. However, Amgen and Merck are proving to be in the vanguard of developing biosimilar adalimumab for the US.

Key Topics Covered:

  1. More Work Remains To Be Done On Canadian Generic Drug Pricing
  2. Teva Canada Launches Tobramycin Inhalation Solution
  3. Mylan's Fluticasone+salmeterol ANDA Accepted By FDA
  4. Lannett Gains Sumatriptan Nasal Spray Approval
  5. ANI And Dexcel Gain Donepezil Approval
  6. FDA Approves Intellipharmaceutics' Levetiracetam
  7. Hikma On Track To Boost US Generic Injectables Presence
  8. FDA Approves Teligent's Desoximetasone Ointment
  9. FDA Accepts Allergan's Rifaximin ANDA For Filing
  10. Billion Dollar Revenues Beckoning For Impax
  11. Generic Drugs Are Not Contributing To Price Rises
  12. Sandoz Acquires Pfizer's Infliximab In EEA
  13. Abbott Acquisition Positions Mylan To Overtake Sandoz In 2016
  14. Sun's US-Centric Focus Faces Challenge
  15. Acquisitions Will Stem Cipla's Falling Revenues

For more information visit http://www.researchandmarkets.com/research/rpxgw4/world_generic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Generic Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Generic Drugs